Category: Myeloproliferative Neoplasm
Management of Advanced Phase Myeloproliferative Neoplasms
Abstract: The BCR-ABL1–negative myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis, can evolve into a form of secondary acute myeloid leukemia termed […]
Novel Therapeutic Approaches in Polycythemia Vera
Abstract: Polycythemia vera (PV) is the most common Philadelphia chromosome–negative myeloproliferative neoplasm. Whereas low-risk patients are treated with aspirin and phlebotomy, high-risk patients receive cytoreductive […]